跳到主要內容

臺灣博碩士論文加值系統

(44.192.92.49) 您好!臺灣時間:2023/06/08 06:51
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:翁慧婷
研究生(外文):Hui-Ting Weng
論文名稱:攝取米飯頻率不同對肥胖者減重效果之影響
論文名稱(外文):Effect of different frequency of rice intake on weight loss in obese people
指導教授:黃惠煐黃惠煐引用關係
指導教授(外文):Hui-Ying Huang
學位類別:碩士
校院名稱:中國醫藥大學
系所名稱:營養學系碩士班
學門:醫藥衛生學門
學類:營養學類
論文種類:學術論文
論文出版年:2013
畢業學年度:101
語文別:中文
論文頁數:109
中文關鍵詞:肥胖身體質量指數體位改善血液生化值米飯攝取
外文關鍵詞:obesitybody mass index(BMI)anthropometry improvementhematology laboratory evaluationsrice intake
相關次數:
  • 被引用被引用:2
  • 點閱點閱:498
  • 評分評分:
  • 下載下載:2
  • 收藏至我的研究室書目清單書目收藏:0
米飯在減肥飲食中扮演的角色眾說紛紜,認為米飯含有較高澱粉,容易造成肥胖,但根據2005-2008年「國民營養健康狀況變遷調查」,無論男女其過胖之比率,皆有增加之趨勢,且和米飯攝取頻率呈反比,因此本研究擬探討米飯對減肥者在體位及相關指標之影響。以身體質量指數(BMI)≧ 30 kg/m2之60位受試者為對象,實驗組與對照組分別各30人。以12週減重課程介入,包括運動、心理及營養等,實驗組強調以米食為主之減重飲食原則。於第0及12週進行血液生化值、體位、24小時飲食回憶、SF-36及WHO生活品質問卷等資料收集。結果顯示:實驗組每週米飯攝取為9次高於對照組之每週8次,且無論實驗組或對照組在經十二週介入後體重、體脂肪重、身體質量指數、礦物質重、除脂重、全身肌肉重、基礎代謝率、總熱量需求、血壓、腹部肥胖率、腰圍、臀圍、內臟脂肪面積、內臟脂肪重、皮下脂肪重、左(右)手臂脂肪、左(右)腿脂肪、軀幹脂肪、左(右)腿肌肉、麩草醋酸轉胺酶、麩丙酮酸轉胺酶、熱量及蛋白質均顯著下降( p < 0.05)。體適能項目包括登階及柔軟度,兩組皆有顯著增加的情形( p< 0.05)。實驗組與對照組相比,在體重、BMI、蛋白質重、除脂重、全身肌肉重、基礎代謝率、總熱量需求、腹部肥胖率、白血球、血色素、麩草醋酸轉胺酶、麩丙酮酸轉胺酶、三酸甘油酯等皆達顯著改善( p < 0.05)。而實驗組之代謝症候群比例下降30%,對照組則下降13.4%。在WHO及SF-36生活品質問卷方面,實驗組及對照組在SF-36問卷,其一般健康(GH)、活力狀況(VT)皆顯著上升( p < 0.05),而實驗組在WHO生活品質問卷之心理及生理構面亦具顯著上升( p < 0.05)。實驗組與對照組相比,在生活品質方面皆無顯著差異。因此,減重其間以低熱量飲食搭配米飯,並輔以運動,更有利於體重及相關指標改善。

There are many different views on the role of rice in the diets for body weight reduction. One such view is that rice has higher content of starch which easily leads to weight gain. According to the Nutrition and Health Survey in Taiwan from 2005 to 2008 (NAHSIT 2005-2008), there was an increase in prevalence of obesity in both men and women while there was a decrease in frequency of rice intake. The purpose of the study was to investigate the effect of rice intake on obese adults. There were 60 subjects (with BMI≧30) who had rice intake frequency≧8 times on weekly basis who were assigned to two groups, 30 subjects in each experimental and control group. All subjects took part in a 12-week weight reduction program. The program included exercise, psychological and nutritional education. The nutritional education of experimental (treatment) group component emphasized the principle related to rice consumption in weight reduction. Measurements were taken at week o and 12, including hematology laboratory evaluations, and anthropometry (e.g., height, weight), 24-hour dietary recall, short-form 36 health survey, and the brief version of the World Health Organization Quality of Life. After the 12 weeks treatment period, experimental (treatment) group’s subjects who had rice intake frequency ≧ 9 times higher than control group’s. And subjects. the subject’s intake of energy and protein and subject’s body weight, body fat mass, BMI, mineral, fat-free mass, muscle mass, BMR, total energy expenditure, blood pressure, abdominal [obesity], waistline, hips, visceral fat area, visceral fat weight, subcutaneous fat weight, left (right) arm fat, left (right) leg fat, trunk fat, left (right) leg [lean], GOT, and GPT all showed significant decrease in both groups. The physical fitness was enhanced which included step and fitness exercise in both groups. Besides, the loss of body weight, BMI, protein, fat free mass, muscle mass, BMR, total energy expenditure, [abdominal obesity], WBC, hemoglobin, GOT, GPT and TG in treatment group were significantly different from those of control group in 12 weeks. The total rate of metabolic syndromes for the treatment group improved 30% compared with the control group’s 13.4%. Moreover, general health and vitality quality of life showed significant difference after intervention in both groups. Mental and physical domain of the WHOQOL-BREF significantly increased in treatment groups. There was no significant difference in quality of life between experimental group and control group. Therefore, it would increase the effectiveness on weight loss and related indicators that giving moderate rice diet combined with exercise to those overweight and obese individuals. This study showed that low-energy diet with rice intake, in combination with exercise, was helpful for body weight improvement in overweight and obese individuals.

目 錄
謝誌………………………………………………………………………………………I
目錄………………………………………………………………………………………II
圖目錄…………………………………………………………………………………VI
表目錄…………………………………………………………………………………VII
縮寫表…………………………………………………………………………………IX
中文摘要………………………………………………………………………………XI
英文摘要………………………………………………………………………………..XII

第一章 緒論………………………………………………………………………………1
第二章 文獻回顧
第一節 肥胖的定義
一、 世界衛生組織(World Health Organization)的定義…………..2
二、 亞洲地區的定義………………………………………………..3
三、 衛生署的定義…………………………………………………3
第二節 肥胖問題的探討
一、 肥胖的盛行率…………………………………………………5
二、 肥胖對健康的影響……………………………………………..7
第三節 稻米之介紹
一、 米食攝取之迷思………………………………………………11
二、 稻米的構造組成………………………………………………11
三、 稻米的品種……………………………………………………12
四、 稻米的營養以及其對人體健康之影響………………………13
五、 台灣稻米種植現況、米食及醣類攝取量與肥胖率變化情形..15
六、 各種主食1份所含的營養成份……………………………….16
第四節 生活品質之測量
一、 生活品質之概念………………………………………………17
二、 WHOQOL-BREF台灣簡明版的發展………………………..18
三、 SF-36健康量表起源與介紹………………………………….20
四、 評估SF-36健康量表(methods of administration)方法的
研究……………………………………………………………21
第三章 研究目的………………………………………………………………………..22
第四章 研究方法
第一節 研究架構………………………………………………………………23
第二節 研究設計………………………………………………………………24
第三節 研究對象………………………………………………………………28
第四節 研究工具………………………………………………………………28
第五節 資料處理與統計分析…………………………………………………37
第五章 研究結果
第一節 研究對象之基本資料
1-1. 體位狀況………………………………………………………39
1-2. 血液生化值狀況………………………………………………40
1-3. 體適能狀況……………………………………………………41
1-4. 飲食狀況………………………………………………………41
1-5. 結論……………………………………………………………...41
第二節 營養教育課程之不同對受試者飲食部分之影響
2-1. 熱量及三大營養素之變化……………………………………41
2-2. 結論……………………………………………………………...42
第三節 營養教育課程之不同對受試者體位改善之結果
3-1. 血壓及體位變化………………………………………………42
3-2. 腹部肥胖分析…………………………………………………43
3-3. 四肢及軀幹之肌肉及脂肪分析………………………………43
3-4. 身體類型………………………………………………………44
3-5. 結論……………………………………………………………...44
第四節營養教育課程之不同對受試者血液生化值改善之結果
4-1. 血液生化值之分析……………………………………………45
4-2. 結論……………………………………………………………...46
第五節 營養教育課程之不同對改善代謝症候群危險因子之結果
5-1. 改善代謝症候群盛行率的效果………………………………46
5-2. 改善代謝症候群危險因子異常個數之效果…………………46
5-3. 結論……………………………………………………………...47
第六節 營養教育課程之不同對受試者體適能改善之結果
6-1. 體適能改善情況………………………………………………47
6-2. 結論……………………………………………………………...47
第七節 營養教育課程之不同對受試者生活品質之改善
7-1. SF-36健康生活品質量表 & WHOQOL-BREF……………………48
7-2. 結論……………………………………………………………...50
第六章 討論
第一節 營養教育課程之不同對受試者飲食攝取之影響………72
第二節 營養教育課程之不同對受試者體位測量值影響之探討………73
第三節 營養教育課程之不同對相關血液值改善之影響
3-1. 對血液檢查(白血球、血色素及促甲狀腺素)之
改善效果…………………………………………………………74
3-2. 對肝功能(麩草醋酸轉胺酶、麩丙酮酸轉胺酶)之改善效果…74
3-3. 對血清尿酸之改善效果………………………………………75
3-4. 對血清膽固醇之改善效果……………………………………75
3-5. 對血清低密度脂蛋白膽固醇之改善效果……………………76
第四節 營養教育課程之不同對代謝症候群危險因子改善之影響
4-1. 對腰圍之改善效果……………………………………………76
4-2. 對血脂質之改善效果…………………………………………77
4-3. 對空腹血糖之改善效果………………………………………77
4-4. 對血壓之改善效果……………………………………………78
第五節 營養教育課程之不同對改善受試者體適能之影響……..…78
第六節 營養教育課程之不同對改善受試者生活品質之影響…….79
第七章 結論……………………………………………………………………………..80
參考文獻…………………………………………………………………………………81
附錄………………………………………………………………………………………93













圖 目 錄
圖一、19-64歲成年男女性攝入主食類之趨勢………………………………………16
圖1、研究目的…………………………………………………………………………...22
圖2、研究架構…………………………………………………………………………...23
圖3、成人腰圍的測量…………………………………………………………………...33
圖1-1-1. 實驗組及對照組米飯攝取狀況………………………………………………66
圖1-1-2. 實驗組及對照組主食類攝取比較……………………………………………66
圖1-1-3. 實驗組及對照組熱量攝取變化………………………………………………67
圖1-1-4. 實驗組及對照組蛋白質攝取變化……………………………………………67
圖1-1-5. 實驗組及對照組脂肪攝取變化………………………………………………68
圖1-1-6. 實驗組及對照組碳水化合物攝取變化………………………………………68
圖3-4-1. 經十二週介入後,實驗組及對照組學員體型之變化……………………...69
圖5-1-1. 經由減重課程介入後代謝症候群之盛行率變化……………………………69
圖5-2-1. 實驗組代謝症候群危險因子異常率之變化………...……………………….70
圖5-2-2. 對照組代謝症候群危險因子異常率之變化…………………………………70
圖7-1-1. 評估自身的生活品質…………………………………………………………71
圖7-1-2. 評估自身的健康狀況…………………………………………………………71










表 目 錄
表一、世界衛生組織於1988年對肥胖之定義…………………………………………2
表二、建議亞洲成人對肥胖之定義………………………………………………………3
表三、成人肥胖定義………………………………………………………………………4
表四、因肥胖造成之健康問題,其相對危險性…………………………………………10
表五、民國70-100年國人米食食用量變遷……………………………………………15
表六、1993-1996年與2005-2008熱量、三大營養素與肥胖比率之關係……………16
表七、各種主食1份所含的營養成份…………………………………………………17
表八、實驗組及對照組課程相異之處…………………………………………………25
表九、實驗組之營養課程………………………………………………………………26
表十、對照組之營養課程………………………………………………………………27
表十一、WHOQOL-BREF的範疇及層面架構………………………………………30
表1-1-1、受試者體位基本資料…………………………………………………………51
表1-1-2、受試者腹部肥胖分析基本資料………………………………………………51
表1-1-3、四肢及軀幹之肌肉及脂肪分析………………………………………………52
表1-2-1、受試者血液生化值之基本資料………………………………………………52
表1-3-1、受試者體適能基本資料………………………………………………………53
表1-4-1、受試者飲食基本資料…………………………………………………………53
表2-1-1、實驗組及對照組介入前、後測飲食之變化…………………………………54
表3-1-1、實驗組及對照組介入前、後測血壓及體位之變化…………………………55
表3-1-2、經性別校正後,實驗組及對照組介入前、後測血壓及體位之變化……..56
表3-2-1、實驗組及對照組介入前、後測腹部肥胖之變化…………………………….57
表3-3-1、實驗組及對照組介入前、後測四肢及軀幹之肌肉及脂肪分析…………….58
表3-2-2、經性別校正後,實驗組及對照組介入前、後測腹部肥胖之變化……….59
表3-3-2、經性別校正後,實驗組及對照組介入前、後測四肢及軀幹之肌肉及脂肪
分析…………………………………………………………………………………59
表4-1-1、實驗組及對照組介入前、後測血液生化值之變化…………………………60
表4-1-2、經性別校正後,實驗組及對照組介入前、後測血液生化值之變化…………61
表5-2-1、代謝症候群危險因子異常個數之改變情形…………………………………62
表6-1-1、實驗組及對照組,每週運動分鐘數…………………………………………...63
表6-1-2、實驗組及對照組介入前、後測體適能之變化……………………………….63
表6-1-3、經性別校正後,實驗組及對照組介入前、後測體適能之變化……………….64
表7-1-1、實驗組及對照組前、後測生活品質各構面之得分情形……………………..65


參考文獻
行政院衛生署(2011)。2005-2008國民營養健康狀況變遷調查結果。取自:
http://nahsit.nhri.org.tw/node/15
行政院衛生署。國人肥胖定義及處理原則出爐。民94年3月1日,取自:http://www.doh.gov.tw/CHT2006/DM/DM2_p01.aspx?class_no=25&now_fod_list_no=3942&level_no=2&doc_no=32.
行政院農業委員會農糧局統計室(2013年1月)。台灣地區農產統計報告。台北市:行政院農業委員會農糧局。取自:
http://agrstat.coa.gov.tw/sdweb/public/book/Book.aspx
行政院衛生署食品藥物管理局。台灣地區食品營養成分資料庫。取自:
http://consumer.fda.gov.tw/FoodAnalysis/ingredients.htm
吳幸娟、吳佳娟、金惠民、胡淑惠、陳惠欣、章樂琦、張琳、黃惠煐、曾美智、劉慧蓉、蔡秀玲(2010)。營養評估 四版。華格那企業有限公司。
林秀卿、林彥斌(2007)。食物學概論。新文京開發出版股份有限公司。
李素箱、徐志輝(2003)。社區健康營造之台中地區民眾運動習慣與體適能相關研究。2003年台灣體育運動與健康休閒發展趨勢研討會。
陳肅霖、徐近平、蔡文騰、劉佳玲、徐永鑫、黃湞鈺、江孟燦、江淑華、黃千純、林志城(2007)。新編食物學原理。華格那企業有限公司。
程修和(2009)。食物學原理。華都文化事業有限公司。
施明智(2004)。食物學原理 第二版。藝軒圖書出版社。
黃士懿(1998)。漫談成人型肥胖。中化藥訊 39, 1-9。
黃伯超、游素玲(2011)。吃米飯會發胖? 減肥一定不能吃米飯嗎?。健康世界 12月號。
葉志嵘、張新儀、潘文涵。台灣近十二年之肥胖與代謝症候群之變遷趨勢:由NAHSIT
1993-1996到2005-2008。2005-2008台灣營養健康調查:141-154。
張家偉、黃娟娟(2009)。運動對於健康狀況所產生影響之探討。2009年海峽兩岸創新與永續經營學術研討會暨2009管理創新與科技整合學術研討會。June 11, 2009 Hsinchu, Taiwan。
彭仁奎、黃國晉、陳慶餘(2006)。肥胖與代謝症候群。基礎醫學 21(12), 367-371。
賴明宏(1995)。飲食中補充米麩或三價鉻對第二型糖尿病患或STZ誘導的糖尿病大白鼠醣類及脂質代謝之影響。私立台北醫學大學藥學研究所食品化學組碩士論文。
劉美媛(1997)。不同程度肥胖女性減重前後之體組成、熱量代謝及血液生化值變化之研究。私立台北醫學大學保健營養學系碩士論文。
蘇榮基(2002)。體適能檢測的探討。勤益學報第二十卷第二期。
盧令儀(2000)。某教學醫院冠狀動脈疾病病患施行心臟相關手術術後生活品質之探討。未發表之碩士論文。台北:長庚大學管理學研究所醫務管理組。
潘文涵、吳幸娟、葉志嶸、莊紹源、張新儀、葉乃華、謝耀德。台灣人飲食
與健康之趨勢:1993-1996 與 2005-2008 兩次營養健康調查之比較。2005-2008
台灣營養健康調查:17-40。
程淑媛(2009)。血液透析患者生活品質相關因素探討。澄清醫護管理雜誌。5(2), 31-40
姚開屏(2002)。台灣版世界衛生組織生活品質問卷之發展與應用。台灣醫學。6(3), 193-200。
鄭舜平(2005)。健走訓練對社區老人健康生活品質與成本效用影響之探討。未發表碩士論文。台北:台灣大學公共衛生學院醫療機構管理研究所。
鄭心嫻、謝明哲、朱哲輝(1991)。白米、糙米及添加聚糊精的白米飲食對青年男子代謝的影響. 中華營誌 16(3.4),157-175。
A.W. (2005).Thorburn. Prevalence of obesity in Australia. The International Association for the Study of Obesity. Obesity reviews 6, 187-189.
Abate N(1999). Obesity as a risk factor for cardiovascular disease. Am J Med 107(suppl), 12S–3S
Alicja Wolk, Gloria Gridley, Malin Svensson, Olof NyreAn, Joseph K. McLaughlin, Joseph F. Fraumeni, Jr, Hans-Olov Adami(2001). A prospective study of obesity and cancer risk (Sweden). Obesity and cancer 12,13-21.
Almedia, N.G., Levitski, D.A. & Strupp, B(1996). Enhanced thermogenesis during recovery from diet induced weight gain in the rat. Am. J. Physiol 271, R1380-1387.
Aaronson NK, Acquadro C, Alonso J, Apolone G, Bucquet D, Bullinger M, et al. (1992). International quality of life assessment (IQOLA) project. Quality Life Res 1, 349–351.
Chang-Wan Han, Eun-Joo Lee, Tsutomu Iwaya, Hitomi Kataoka, Masahiro Kohzuki (2004). Development of the Korean Version of Short-Form 36-Item Health Survey: Health Related QOL of Healthy Elderly People and Elderly Patients in Korea. The Tohoku Journal of Experimental Medicine 203, 189-194.
Cynthia L. Ogden, Margaret D. Carroll, Brian K. Kit, and Katherine M. Flegal (2012).
Prevalence of Obesity in the United States, 2009–2010. NCHS Data Brief 82, 1-8.
Chan, J. M., Stampfer, M. J., Rimm, E. B., Willett, W. C, Colditz, G. A.(1994). Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17(9), 961-969.
Colditz, G. A. (1992). Economic costs of obesity. Am J Clin Nutr. 55 (Suppl 2), 503S–507S.
Dattilo AM, and Kris-Etherton PM(1992). Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. American Journal Clinical Nutrition 56, 320-328.
Emily A Hu, An Pan , Vasanti Malik , Qi Sun (2012). White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. BMJ 344, e1454
Elisa Fabbrini, Shelby Sullivan and Samuel Klein (2012). Obesity and Nonalcoholic Fatty Liver Disease:Biochemical, Metabolic, and Clinical Implications. HEPATOLOGY 51(2) , 679-689.
Elkind MS, Cheng J, Boden-Albala B, Paik MC, Sacco RL (2001). Northern Manhattan Stroke Study: Elevated white blood cell count and carotid plaque thickness: the Northern Manhattan Stroke study. Stroke 32, 842–849.
Eugenia E Calle , Michael J Thun(2004). Obesity and cancer. Oncogene. 23, 6365–6378
Eugenia E. Calle, Rudolf Kaaks(2004). Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer 4(8), 579-591
Emma Farnsworth, Natalie D Luscombe, Manny Noakes, Gary Wittert, Eleni Argyiou, and Peter M Clifton (2003). Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women. Am J Clin Nutr 78, 31–39
Fang J and Alderman MH (2000). Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow-up study.1971-1992. JAMA 283, 2404-2411.
Fantuzzi G. (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919;quiz 920.
Ferraro, R., Lillioja, S., Fontvieille, A-M., Rising, R., Bogardus, C. , Ravussin, E.(1992). Lower sedentary metabolic rate in woman compared with men. J. clin. Invest 90, 780-784.
Festa A, D’Agostino R Jr, Howard G, et al. (2000). Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study(IRAS). Circulation 102, 42-47.
Festa A, D’Agostino R Jr, Tracy RP, et al. (2002). Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51, 1131-1137.
Fisch IR, Freedman SH. (1975). Smoking, oral contraceptives, and obesity. Effects on white blood cell count. JAMA 234 , 500-506.
Ford ES, Giles WH,Dietz WH. (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356-359.
Fontaine KR, Cheskin LJ, Barofsky I. (1996). Health-related quality of life in obese persons seeking treatment. J Fam Pract. 43(3), 265-70.
Frank B. Hu, JoAnn E. Manson, Meir J. Stampfer, Graham Colditz, Simin Liu, Caren G. Solomon, and Walter C. Willett (2001). Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in Women. The New England Journal of Medicine 345(11), 790-797.
Franca Bianchini, Rudolf Kaaks, and Harri Vainio (2002). Overweight, obesity, and cancer risk. THE LANCET Oncology 3, 565-574
Freedman DS, Serdula MK, Srinivasan SR, Berenson GS (1999) . Relation of circumferences and skinfold thicknesses to lipids and insulin concentrations in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 69 , 308–317.
Fontaine K. R. andBarofsky I. (2001). Obesity and health-related quality of life. The International Association for the Study of Obesity. obesity reviews 2,173–182.
Ge, L. (1997). Body mass index in young Chinese adults. Asia Pacific Journal of
Clinical Nutrition 6 , 175-179.
George A Bray(1998). Dietary fat intake does affect obesity! Am J Clin Nutr 68 , 1157–73.
Giovannucci, E. et al.(1995). Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann. Intern. Med. 122, 327-334.
Harry Hemingway, Mai Stafford, Stephen Stansfeld, Martin Shipley, Michael Marmot (1997). Is the SF-36 a valid measure of change in population health? Results from the Whitehall II study. BMJ. 315(15) , 1273-1279.
Helen A. Doll, Sophie E. K. Petersen, and Sarah L. (2000). Stewart-Brown Obesity and Physical and Emotional Well-Being: Associations between Body Mass Index, Chronic Illness, and the Physical and Mental Components of the SF-36 Questionnaire. OBESITY RESEARCH 8(2), 160-170.
Ian Janssen, Peter T Katzmarzyk, and Robert Ross (2004) . Waist circumference and not body mass index explains obesity related health risk. Am J Clin Nutr.79, 379-384.
Jakicic JM, Clark K., Coleman E., Donnelly JE, Foreyt J., Melanson EL, Volek J., Volpe SL (2001) , American College of Sports Medicine .American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med. Sports Exerc. 33, 2145 -2156.
John E. Ware, Jr., and Barbara Gandek (1998). Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 51(11), 903–912.
Jing Fang, Michael H. Alderman (2000). Serum uric acid and morality: The NHANESI epidemiologic follow-up study, 1971-1992. National and Nutrition Examination Survey, JAMA, 283, 2404-2410. doi:10.1001/jama.283.18.2404.
Kim D. M., Ahn C. W. and. Nam S. Y (2005). Prevalence of obesity in Korea. The International Association for the Study of Obesity. Obesity reviews 6, 117-121.
Kolotkin RL, Meter K, Williams GR (2001). Quality of life and obesity. Obes Rev 2, 219-29.
Larsson U, Karlsson J and Sullivan M (2002). Impact of overweight and obesity on health-related quality of life — a Swedish population study. International Journal of Obesity 26:417–424.
Lee IM (1996). Is weight loss hazardous? Nutrition Review 54, S117-S124.
Lee YH, Pratley RE. (2005). The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 5, 70-75.
Leung,K,F,,Chu,M.ML., & Lau, J.T.F.(1997). Cultural relevancy of WHOQOL structure in Hong Kong Chinese.
Li G., Chen X., Jang Y., Wang J., Xing X., Yang W. and Hu Y. (2002). Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population. The International Association for the Study of Obesity. obesity reviews 3, 167-172.
Li GH, Qu MR, Wan JZ, You JM. (2007). Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin Iconverting enzyme inhibitory activity in spontaneously hypertensive rats. Asia Pac J Clin Nutr. 16(Suppl), 275-280.
Manocchia M, Bayliss MS, Connor J, Keller SD, Shiely J-C, Tasai C, et al.(1998). SF-36 Health Survey Annotated Bibliography: Second Edition (1988–1996). Boston, MA: The Health Assessment Lab, New England Medical Center.
MacMahon S, Cutler J, Brittain E, Higgins M.(1987). Obesity and hypertension: epidemiological and clinical issues. Eur Heart J. 8(Suppl b), 57–70.
McHorney CA, Kosinski M, Ware JE.(1994). Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a nation survey. Medical Care 32(6), 551-567.
Meigs JB.(2002). Epidemiology of the metabolic syndrome,2002. Am J Manag Care 8, S283-S292.
Neovius M., Janson A., Rossner S. (2006). Prevalence of Obesity in Sweden. The International Association for the Study of Obesity. Obesity reviews 7, 1-3.
National Heart, Lung and Blood Institute (1998).Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. Obes.
National Institute of Health (2001). Third Report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel, or ATP III). National Institutes of Health Publication No.02-5215.
Powell JJ, Tucker L, Fisher AG, Wilcox K (1994). The effects of different percentages of dietary fat intake, exercise, and calorie restriction on body composition and body weight in obese females. Am J Health Promot 8, 442–448.
Petrelli J. M., Calle E. E., Rodriguez, C. , Thun M. J. (2002). Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of U. S. women. Cancer Causes Control 13, 325–332.
Pi-Sunyer FX (1993). Short-term medical benefit and adverse effects of weight loss. Annals of Internal Medicine 119, 722-726.
Pischon T, Lahmann PH, Boeing H et al. (2006). Body Size and Risk of Colon and Rectal Cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Journal of the National Cancer Institute 98(13), 920-931.
Quesenberry, C. P. Jr, Caan, B., Jacobson, A. (1998). Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med.158, 466–472.
Ravussin, E., Lillioja, S., Anderson, T.E., Christin, L., Bogardus, C. (1986). Determinants of 24-hour energy expenditure in man. J. Clin. Invest., 78: 1568-1578.
Rosenthal A D, Jin F, Shu X-O, Yang G, Elasy T A, Chow W-H, Ji B-T, Xu H-X, Li Q,
Gao Y-T and Zheng W (2004). Body fat distribution and risk of diabetes among Chinese women. International Journal of Obesity 28 , 594-599.
Roland T Jung. (1997). Obesity as a disease. British Medical Bulletin.53 (2), 307-321.
Rippe, J. M., Crossley, S., Ringer, R.(1998).Obesity as a chronic disease: modern medical and lifestyle management. J Am Diet Assoc. 98, S9–S15.
Skov AR, Toubro S, Runn B, Holm L and Astrup A (1999). Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. International Journal of Obesity 23, 528-536.
Stamler R, Stamler J, Riedlinger WF, Algera G, and Roberts RH. (1978). Weight and blood pressure: findings in hypertension screening of 1 million Americans. Journal of the American Medical Association 240, 1607-1610.
Stampfer MJ, Maclure KM, Colditz KM et al.(1992). Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 55, 652-658.
Staels, B., J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J. C. Fruchart. (1998). Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 98, 2088–2093.
Stewart, A.L., Brook, R.H.(1983). Effects of being overweight. American Journal of Public Health 73,171-178.
Szabo, S.(1996). Chap 36: The World Health Organization Quality of Life(WHOQOL) assessment instrument. In B. Spiker (ed.) Quality of life and pharmacoeconomics in clinical trials(pp.355-362) Philadelphia: Lippincott-Raven.
The WHOQOL Group (1994a). Development of the WHOQOL:Rationale and current status.International. Journal of. Mental Health,23(3),24-56.
The WHOQOL Group (1995).The World Health Organization Quality of Life assessment (WHOQOL):Position paper from the World Health Organization. Social Science Medicine,46(12),1569-1585.
Vidal-Puig, A.J., Considine, R.V., Jimenez-Linan, M., Werman, A., Pories, W., Caro, J.F., Flier J.S. (1997). Peroxisome proliferator-activated receptor gene expression in human tissues. J. Clin. Invert. 99, 2416-2422.
Visscher TLS, Kromhout D and Seidell JC (2002). Long-term and recent time trends in the prevalence of obesity among Dutch men and women. International Journal of Obesity 26, 1218–1224.
Veronelli A, Laneri M, Ranieri R, Koprivec D, Vardaro D, Paganelli M, Folli F, Pontiroli AE.(2004). White blood cells in obesity and diabetes: effects of weight loss and normalization of glucose metabolism. Diabetes Care. 27(10), 2501-2502.
Ware, J.E., Snow, K.K., Kolinski, M., Gandeck, B. (1993). SF-36 Health survey manual and interpretation guide. The Health Institute, New England Medical Centre, Boston, MA..
Ware JE, Gandek B, IQOLA Project Group (1994). The SF-36 Health Survey: Development and use in mental health research and the IQOLA project. Int J Ment Health 23, 49–73.
Weinberger M. et al. (1996). Are health-related quality of life measures affected by the mode of administration? J. Clin. Epidemiol. 49(2), 135-140.
Wisse BE.(2004). The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15, 2792-2800.
Wing, RR & Hill, JO. (2001).Successful weight loss maintenance. Annu. Rev. Nutr. 21, 323 -341.
Wood PD, Stefanick ML, Willians PT, and Haskell WL.(1991). The effects on plasma lipoprotrin of a prudent weight-reducting diet, with or without exercise, in overweight men and woman. The New England Journal of Medicine 325, 461-466.
World Health Organization (1995e). Resources for new WHOQOL centers. Geneva: WHO(MNH/PSF/95.2).
World Health Organization (1996b). WHOQOL-BREF: Introduction,administration, scoring and generic version of the assessment—Field trial version.Geneva: WHO.
World Health Organization (1998). Obesity: Preventing and Managing the Global Epidemic. Geneva: WHO.
World Health Organization (2000). The Asia-Pacific perspective: Redefining obesity and its treatment. Geneva: WHO.
World Health Organization (2002). The world health report 2002. Reducing risks, promoting healthy life. Geneva: WHO.
Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D''Andrea F, Molinari AM, Giugliano D (2002). Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105(7), 804–809.
Zumin Shi , Anne W Taylor, Gang Hu , Tiffany Gill , Gary A Wittert (2012). Rice intake, weight change and risk of the metabolic syndrome development among Chinese adults: the Jiangsu Nutrition Study (JIN). Asia Pac J Clin Nutr 21 (1), 35-43.


QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top